IN8bio Expands Capabilities with the Grand Opening of its Advanced Research and Development FacilityGlobeNewsWire • 08/08/23
IN8bio, Inc. (INAB)'s Technical Outlook is Bright After Key Golden CrossZacks Investment Research • 06/05/23
IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual MeetingGlobeNewsWire • 06/05/23
IN8bio, Inc. (INAB) Is Up 37.87% in One Week: What You Should KnowZacks Investment Research • 05/24/23
IN8bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/12/23
IN8bio Announces New Preclinical Data in Ovarian Cancer to be Presented at ASGCT 26th Annual MeetingGlobeNewsWire • 05/02/23
IN8bio Announces Oral Presentation of New INB-200 Phase 1 Data in Glioblastoma (GBM) to be Presented at 2023 ASCO Annual MeetingGlobeNewsWire • 04/26/23
IN8bio stock price falls even as company receives FDA orphan drug status for brain cancer treatmentProactive Investors • 04/25/23
IN8bio Receives FDA Orphan Drug Designation for INB-400/410 for the Treatment of Newly Diagnosed GlioblastomaGlobeNewsWire • 04/25/23
IN8bio Presents Positive, New INB-100 Data Showing Long-term Complete Remissions and Elevated Gamma-Delta T Cells in 100% of Evaluable Treated Leukemia Patients at EBMT 2023GlobeNewsWire • 04/24/23
IN8bio Announces Positive Preclinical Data for Gamma-Delta CAR Platform and Launches New CD33 Program at AACR Annual Meeting 2023GlobeNewsWire • 04/17/23
IN8bio to Present New Positive Clinical Data from Phase 1 Trial of INB-100 at EBMT 2023 Annual MeetingGlobeNewsWire • 04/11/23
IN8bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/30/23
IN8bio to Present Positive Preclinical Data on Novel Gamma-Delta CAR Platform at AACR Annual Meeting 2023GlobeNewsWire • 03/16/23
IN8bio Presents Preclinical Data Showing Non-Signaling CAR Platform Targets Cancer Cells While Preserving Healthy TissueGlobeNewsWire • 02/23/23
IN8bio to Present at the B. Riley Securities' 3rd Annual Virtual Oncology ConferenceGlobeNewsWire • 01/17/23